scPharmaceuticals Inc expected to post a loss of 42 cents a share - Earnings Preview

Scpharmaceuticals

11/03/2024 20:36

* scPharmaceuticals Inc  SCPH.OQ   SCPH.O  is expected
to show a
rise in quarterly revenue when it reports  results on March 13
for the period ending December 31 2023
    * The Burlington Massachusetts-based  company is expected to
report revenue of $5.525 million, according to the mean estimate
from 6 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for scPharmaceuticals Inc is
for a
loss of 42 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $18.00​, above​ its last closing price of $5.38. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.37       -0.36      -0.41     Missed  -12.4
 Jun. 30 2023  -0.37       -0.37      -0.36     Beat    3.3
 Mar. 31 2023  -0.39       -0.36      -0.30     Beat    17.8​
 Dec. 31 2022  -0.34       -0.39      -0.30     Beat    22.5
 ​​Sep.        -0.36       -0.38      -0.37     Beat    3.3
 30 2022                                                
 Jun. 30 2022  -0.30       -0.30      -0.35     Missed  -15.4​
 Mar. 31 2022  -0.32       -0.31      -0.28     Beat    9.7
 Dec. 31 2021  -0.32       -0.34      -0.27     Beat    21.4
 This summary was machine generated March 11 at 20:36 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)